Title
Factors associated with HIV viral suppression among transgender women in Lima, Peru
Date Issued
01 December 2018
Access level
open access
Resource Type
journal article
Author(s)
Rich K.M.
Wickersham J.A.
Valencia Huamaní J.
Kiani S.N.
Cabello R.
Elish P.
Florez Arce J.
Pizzicato L.N.
Sanchez J.
Altice F.L.
Publisher(s)
Mary Ann Liebert Inc.
Abstract
Purpose: Globally, transgender women (TGW) experience a high burden of adverse health outcomes, including a high prevalence of HIV and sexually transmitted infections (STIs) as well as psychiatric disorders and substance use disorders. To address gaps in HIV research in Peru focused specifically on TGW, this study presents characteristics of a sample of HIV-positive TGW and identifies factors associated with viral suppression. Methods: Between June 2015 and August 2016, 50 HIV-positive TGW were recruited in Lima, Peru. Multivariable logistic regression was used to identify factors associated with viral suppression (<200 copies/mL) among the TGW. Results: Among TGW, 85% achieved viral suppression. Approximately half (54%) reported anal sex with more than five partners in the past 6 months, 38% reported sex work, 68% had not disclosed their HIV status to one or more of their partners, and 38% reported condomless sex with their last partner. The prevalence of alcohol use disorders was high (54%), and 38% reported use of drugs in the past year. Moderate-to-severe drug use significantly reduced odds of achieving viral suppression (adjusted odds ratio 0.69; 95% confidence interval: 0.48-0.98). Conclusion: Our findings highlight the need for integrated treatment for substance disorders in HIV care to increase the viral suppression rate among TGW in Lima, Peru.
Start page
477
End page
483
Volume
5
Issue
8
Language
English
OCDE Knowledge area
Urología, Nefrología
Epidemiología
Obstetricia, Ginecología
Salud pública, Salud ambiental
Subjects
Scopus EID
2-s2.0-85058513162
PubMed ID
Source
LGBT Health
ISSN of the container
23258292
Sponsor(s)
The authors gratefully acknowledge the individuals who gave their time to participate in this study; the medical and research personnel at IMPACTA Peru, Vía Libre, Hospital Nacional Dos de Mayo, and Hospital Nacional Arzobispo Loayza; and the research personnel at the Yale AIDS Program for their continued support of this study. This research was made possible by generous financial support from the National Institute on Drug Abuse (K24 DA017072 and K01 DA038529 for JAW) and from Yale University with the following student fellowships: The Charles P. Howland Fellowship, the Overlook International Foundation, The Downs International Health Student Travel Fellowship, The Latin American and Iberian Studies Travel Award, The Yale Global Health Field Experience Award, the Yale College Fellowship for Juniors, and the Global Health Seed Funding Fellowship.
Sources of information:
Directorio de Producción Científica
Scopus